Your Fastest Path to Indonesia Trial Readiness Starts Here

Kind Shark helps global life-science teams assess feasibility, identify the right sites, and activate compliant pathways into Indonesia—before making large operational commitments.

We work within Ministry governance and privacy-preserving environments to translate what’s possible—safely—from national systems into decision-ready outputs. When sponsors are ready, we help move from “insight” to “activation” through qualified local pathways.

De-risk. Decide. Activate

Explore More

A New Standard for Emerging-Market Trial Partnerships

Our Mission

Kind Shark exists to make clinical research in emerging markets credible, faster, and safer—for sponsors, sites, and patients. We do this by combining (1) privacy-preserving analytics under government governance and (2) on-the-ground activation support that helps teams start with clarity instead of assumptions.

Our Vision

A world where high-quality clinical trials can expand globally without compromising data sovereignty, ethics, or trust—and where patient access improves because feasibility and execution are built on real-world constraints, not slide-deck optimism.

Operating in close collaboration with Indonesia Ministry of Health and aligned stakeholders, we focus on scalable models that can be repeated across therapeutic areas and regions.

Learn More

ABOUT KIND SHARK

Kind Shark is an AI-enabled clinical research partner helping sponsors enter Indonesia with decision-grade feasibility and responsible activation pathways. We support trial planning, site selection readiness, and recruitment enablement—while respecting Ministry governance and privacy requirements.

What we actually do

• Readiness & feasibility: clarify what can be answered responsibly, with safe outputs suitable for planning.

• Site & ecosystem activation: help sponsors identify and engage qualified sites, investigators, labs, and operational partners.

• Recruitment enablement: build compliant pathways to reach eligible participants through approved channels (sites and patient organizations), without exposing raw personal data.

Services

Precision Cohort Discovery & Feasibility Signals

We generate privacy-preserving feasibility signals (counts, trends, distributions) to help sponsors understand where patients likely are, what data exists, and what questions can be answered responsibly under governance.

Site & Investigator Readiness

We help sponsors identify and qualify sites and investigators by assembling the practical inputs that determine feasibility—capabilities, workflow realities, lab/imaging access, and execution readiness—then translate that into sponsor-ready decision materials.

Recruitment Enablement Pathways

Recruitment is the bottleneck. We help sponsors build compliant recruitment pathways through sites and trusted local channels—so enrollment is practical, ethical, and scalable. (Patient outreach is conducted through approved parties and processes.)

Regulatory & Startup Navigation

We support sponsors in understanding the startup path in Indonesia—what is required, what is feasible, and how to sequence steps efficiently in collaboration with local governance and approved partners.

Feasibility Mapping & Prioritization

We translate feasibility signals into clear prioritization—where to start, which regions/sites are most promising, and what constraints need mitigation before launch.

About the Founder

Dr. Diane Gu, Founder & CEO

Dr. Diane Gu, Founder & CEO, is a global health and clinical research operator known for bridging government, health systems, and life-science sponsors with unusual precision and discretion. Her work focuses on a single outcome: making emerging-market trials executable—without compromising governance or trust.

Through Kind Shark, Dr. Gu is building an Indonesia-first model that combines privacy-preserving feasibility intelligence, site readiness enablement, and recruitment support through trusted local partners—so sponsors can move from interest to action with clarity, speed, and compliance.